Link to Additional Information Sample Clauses

Link to Additional Information. A description of this clinical trial will be available on xxxx://xxx.XxxxxxxxXxxxxx.xxx. This Web site will not include information that can identify you. At most, the Web site will include a summary of the results. You can search this Web site at any time. The amount of payment is based on a number of things including the length of the study. Travel pay for this study has been included in the payment. You may be eligible for a travel and hotel bonus payment: • $0.20/mile per one-way trip to or from the CRU based on your home address • For participants traveling long distances, a 1-night hotel stipend ($150.00) for the night prior to your visit(s), if needed Additional travel services may be arranged on your behalf at no cost to you. All payments will be in U.S. dollars. Compensation may be provided on a loadable debit card or by paper check. Pfizer New Haven CRU reserves the right to determine method of payment. If at any time you test positive for drugs of abuse, you will not be paid for your visit. Further, if you test positive for drugs of abuse: • You will not be allowed to be in this study • You may not be allowed to be in any future studies The screening payment is listed below. You will receive this payment within 2 weeks of screening. If you leave the screening early, you will not be paid. Screening Visit at CRU $175.00 Additional payments are made if we ask you to return to the CRU to repeat any screening tests ($100.00 per visit).
AutoNDA by SimpleDocs
Link to Additional Information. A description of this clinical trial will be available on xxxx://xxx.XxxxxxxxXxxxxx.xxx. This Web site will not include information that can identify you. At most, the Web site will include a summary of the results. You can search this Web site at any time. The amount of payment is based on a number of things including the length of the study. You may be eligible for a travel and hotel bonus payment: • $0.20/mile per one-way trip to or from the CRU based on your home address • For participants traveling long distances, a 1-night hotel stipend ($150.00) for the night prior to your visit(s), if needed All payments will be in U.S. dollars. Compensation may be provided on a loadable debit card or by paper check. Pfizer New Haven CRU reserves the right to determine method of payment. If at any time you test positive for drugs of abuse, you will not be paid for your visit. Further, if you test positive for drugs of abuse: • You will not be allowed to be in this study • You may not be allowed to be in any future studies The screening payment is listed below. You will receive this payment within 2 weeks of screening. If you leave the screening early, you will not be paid. Screening Visit at CRU $175.00 Additional payments are made if we ask you to return to the CRU to repeat any screening tests ($100.00 per visit).
Link to Additional Information. A description of this clinical trial will be available on xxxx://xxx.XxxxxxxxXxxxxx.xxx, as required by U.S. Law. This Web site will not include information that can identify you. At most, the Web site will include a summary of the results. You can search this Web site at any time. Valid proof of a Social Security Number (SSN) is required. This is needed before any payment can be made. The amount of payment is based on a number of things including the length of the study. Travel pay for this study has been included in the payment. You may be eligible for a travel and hotel bonus payment: • $0.20/mile per one-way trip to or from the CRU based on your home address • For participants traveling long distances, a 1-night hotel stipend ($150.00) for the night prior to your visit(s), if needed Additional travel services may be arranged on your behalf at no cost to you. All payments will be in U.S. dollars. Compensation may be provided on a loadable debit card or by paper check. Pfizer New Haven CRU reserves the right to determine method of payment. If at any time you test positive for drugs of abuse, you will not be paid for your visit. Further, if you test positive for drugs of abuse: • You will not be allowed to be in this study • You will not be allowed to be in any future studies • You will be removed permanently from our active database The screening payment is listed below. You will receive this payment within 2 weeks of screening. If you leave the screening early, you will not be paid. Screening Visit at CRU $175.00 Additional payments are made if we ask you to return to the CRU to repeat any screening tests ($100.00 per visit).
Link to Additional Information. See Related Documents
Link to Additional Information. A description of this clinical trial will be available on xxxx://xxx.XxxxxxxxXxxxxx.xxx. This Web site will not include information that can identify you. At most, the Web site will include a summary of the results. You can search this Web site at any time. The amount of payment is based on a number of things including the length of the study. Travel pay for this study has been included in the payment. You may be eligible for a travel and hotel bonus payment: $0.25/mile per one-way trip to or from the CRU based on your home address • For participants traveling long distances, a 1-night hotel stipend ($150.00) for the night prior to your visit(s), if needed Additional travel services may be arranged on your behalf at no cost to you. All payments will be in U.S. dollars. Compensation may be provided on a loadable debit card or by paper check. Pfizer New Haven CRU reserves the right to determine method of payment. Payments may be considered taxable income. If you receive $600.00 or more in taxable payments within a calendar year, your earnings will be reported to the Internal Revenue Service (IRS) and you may receive a tax form (1099). Personal information about you, such as your name, address, and Social Security Number (SSN) or Tax Identification Number (TIN), may be provided to the IRS for tax purposes. If you do not provide your SSN or TIN, you may have taxes deducted from your payment and receive a tax form (1099). If you prefer to not receive payment for this study, you may alert your study site. In some countries, compensation may not be allowed due to immigration status. If at any time you test positive for drugs of abuse, you will not be paid for your visit. Further, if you test positive for drugs of abuse: • You will not be allowed to be in this study • You will not be allowed to be in any future studies • You will be removed permanently from our active database The screening payment is listed below. You will receive this payment within 2 weeks of screening. If you leave the screening early, you will not be paid. Screening Visit at CRU $175.00 Additional payments are made if we ask you to return to the CRU to repeat any screening tests ($100.00 per visit).
Link to Additional Information. Grantor Contact Information: Xxxx X. Xxxxxx, III
Link to Additional Information. Link to Full Notice of Funding Opportunity in the Federal Register
AutoNDA by SimpleDocs
Link to Additional Information. NSF Publication 13-595

Related to Link to Additional Information

  • No Additional Information In offering the Shares for sale, the Dealer Manager shall not, and each Soliciting Dealer shall agree not to, give or provide any information or make any representation other than those contained in the Prospectus or the Approved Sales Literature. The Dealer Manager shall not (i) show or give to any investor or prospective investor or reproduce any material or writing that is supplied to it by the Company and marked “broker-dealer use only” or otherwise bearing a legend denoting that it is not to be used in connection with the sale of Shares to members of the public and (ii) show or give to any investor or prospective investor in a particular jurisdiction any material or writing that is supplied to it by the Company if such material bears a legend denoting that it is not to be used in connection with the sale of Shares to members of the public in such jurisdiction.

  • Statement of Additional Information The Manager shall determine from time to time what securities and other investments will be purchased (including, as permitted in accordance with this paragraph, swap agreements, options and futures), retained, sold or exchanged by the Fund and what portion of the assets of the Funds portfolio will be held in the various securities and other investments in which the Fund invests, and shall implement those decisions (including the execution of investment documentation), all subject to the provisions of the Trusts Declaration of Trust and By-Laws (collectively, the Governing Documents), the 1940 Act, and the applicable rules and regulations promulgated thereunder by the Securities and Exchange Commission (the SEC) and interpretive guidance issued thereunder by the SEC staff and any other applicable federal and state law, as well as the investment objectives, policies and restrictions of the Fund referred to above, and any other specific policies adopted by the Board and disclosed to the Manager. The Manager is authorized as the agent of the Trust to give instructions to the custodian of the Fund as to deliveries of securities and other investments and payments of cash for the account of the Fund. Subject to applicable provisions of the 1940 Act and direction from the Board, the investment program to be provided hereunder may entail the investment of all or substantially all of the assets of the Fund in one or more investment companies. The Manager will place orders pursuant to its investment determinations for the Fund either directly with the issuer or with any broker or dealer, foreign currency dealer, futures commission merchant or others selected by it. In connection with the selection of such brokers or dealers and the placing of such orders, subject to applicable law, brokers or dealers may be selected who also provide brokerage and research services (as those terms are defined in Section 28(e) of the Securities Exchange Act of 1934, as amended (the Exchange Act)) to the Funds and/or the other accounts over which the Manager or its affiliates exercise investment discretion. The Manager is authorized to pay a broker or dealer who provides such brokerage and research services a commission for executing a portfolio transaction for the Fund which is in excess of the amount of commission another broker or dealer would have charged for effecting that transaction if the Manager determines in good faith that such amount of commission is reasonable in relation to the value of the brokerage and research services provided by such broker or dealer. This determination may be viewed in terms of either that particular transaction or the overall responsibilities which the Manager and its affiliates have with respect to accounts over which they exercise investment discretion. The Board may adopt policies and procedures that modify and restrict the Managers authority regarding the execution of the Funds portfolio transactions provided herein. The Manager shall also provide advice and recommendations with respect to other aspects of the business and affairs of the Fund, shall exercise voting rights, rights to consent to corporate action and any other rights pertaining to the Fund's portfolio securities subject to such direction as the Board may provide, and shall perform such other functions of investment management and supervision as may be directed by the Board. The Manager may execute on behalf of the Fund certain agreements, instruments and documents in connection with the services performed by it under this Agreement. These may include, without limitation, brokerage agreements, clearing agreements, account documentation, futures and option agreements, swap agreements, other investment related agreements, and any other agreements, documents or instruments the Manager believes are appropriate or desirable in performing its duties under this Agreement.

  • Opportunities for Additional Information Each Purchaser acknowledges that such Purchaser has had the opportunity to ask questions of and receive answers from, or obtain additional information from, the executive officers of the Company concerning the financial and other affairs of the Company, and to the extent deemed necessary in light of such Purchaser’s personal knowledge of the Company’s affairs, such Purchaser has asked such questions and received answers to the full satisfaction of such Purchaser, and such Purchaser desires to invest in the Company.

  • Additional Information to be Furnished The Master Servicer shall furnish to the Issuer and the Indenture Trustee from time to time such additional information regarding the Mortgage Loans and the Bonds as the Issuer and the Indenture Trustee shall reasonably request.

  • OPERATIONAL INFORMATION Rent Schedule and Increases from Previous Quarter Number Monthly Rent Rent Increases Effective of Units Basic / Market Amount Percent Date 1 Bedroom ________ ______________ _________________ ________ 2 Bedroom ________ ______________ _________________ ________ 3 Bedroom ________ ______________ _________________ ________ PROPOSED MAINTENANCE Completed Funded by Type Description or Operations or Amount Planned Reserves ------------------------------------------------------------------------------ Interior Painting ------------------------------------------------------------------------------ Exterior Painting ------------------------------------------------------------------------------ Siding ------------------------------------------------------------------------------ Roofing ------------------------------------------------------------------------------ Drainage ------------------------------------------------------------------------------ Paving ------------------------------------------------------------------------------ Landscaping ------------------------------------------------------------------------------ Playground ------------------------------------------------------------------------------ Community Room ------------------------------------------------------------------------------ Laundry Room ------------------------------------------------------------------------------ Common Areas ------------------------------------------------------------------------------ Carpet ------------------------------------------------------------------------------ Appliances ------------------------------------------------------------------------------ Lighting ------------------------------------------------------------------------------ Other ------------------------------------------------------------------------------ ------------------------------------------------------------------------------ Please describe in detail any major repairs: ------------------------------------------------------------------------------ ------------------------------------------------------------------------------ ------------------------------------------------------------------------------ Exhibit H CONDITION OF PROPERTY THE OVERALL APPEARANCE OF THE BUILDING(S) IS: Excellent Good Fair Bad THE OVERALL APPEARANCE OF THE GROUNDS IS: Excellent Good Fair Bad EXTERIOR CONDITION (Please Check Appropriate Box) ------------------------------------------------------------------------------ Type of Condition Excellent Good Fair Problems/Comments ------------------------------------------------------------------------------ Signage ------------------------------------------------------------------------------- Parking Lots ------------------------------------------------------------------------------- Office/Storage ------------------------------------------------------------------------------- Equipment ------------------------------------------------------------------------------- Community Building ------------------------------------------------------------------------------- Laundry Room ------------------------------------------------------------------------------- Benches/Playground ------------------------------------------------------------------------------- Lawns, Plantings ------------------------------------------------------------------------------- Drainage, Erosion ------------------------------------------------------------------------------- Carports ------------------------------------------------------------------------------- Fences ------------------------------------------------------------------------------- Walks/Steps/Guardrails ------------------------------------------------------------------------------- Lighting ------------------------------------------------------------------------------- Painting ------------------------------------------------------------------------------- Walls/Foundation ------------------------------------------------------------------------------- Roof/Flashing/Vents ------------------------------------------------------------------------------- Gutters/Splashblocks ------------------------------------------------------------------------------- Balconies/Patios ------------------------------------------------------------------------------- Doors Windows/Screens ------------------------------------------------------------------------------- Elevators ------------------------------------------------------------------------------- INTERIOR CONDITION ------------------------------------------------------------------------------- Stairs ------------------------------------------------------------------------------- Flooring ------------------------------------------------------------------------------- Doors/Cabinets/Hardware ------------------------------------------------------------------------------- Drapes/Blinds ------------------------------------------------------------------------------- Interior Painting ------------------------------------------------------------------------------- Refrig/Stoves/Sinks ------------------------------------------------------------------------------- Bathroom/Tubs/Showers Toilets ------------------------------------------------------------------------------- Exhibit H FINANCIAL STATUS

  • Purchaser Information Each Purchaser covenants that it will promptly notify the Company of any changes in the information set forth in the Registration Statement regarding such Purchaser or such Purchaser's "Plan of Distribution."

  • Information The Buyer and its advisors, if any, have been, and for so long as the Note remain outstanding will continue to be, furnished with all materials relating to the business, finances and operations of the Company and materials relating to the offer and sale of the Securities which have been requested by the Buyer or its advisors. The Buyer and its advisors, if any, have been, and for so long as the Note remain outstanding will continue to be, afforded the opportunity to ask questions of the Company. Notwithstanding the foregoing, the Company has not disclosed to the Buyer any material nonpublic information and will not disclose such information unless such information is disclosed to the public prior to or promptly following such disclosure to the Buyer. Neither such inquiries nor any other due diligence investigation conducted by Buyer or any of its advisors or representatives shall modify, amend or affect Buyer’s right to rely on the Company’s representations and warranties contained in Section 3 below. The Buyer understands that its investment in the Securities involves a significant degree of risk. The Buyer is not aware of any facts that may constitute a breach of any of the Company's representations and warranties made herein.

  • User Information Any user or usage data or information collected via Station’s digital properties or related to Station’s digital properties, or any information collected from websites operated by Station’s affiliates under this Agreement, shall be the property of Station and/or such affiliates. Advertiser shall have no rights in such information by virtue of this Agreement.

  • Seller Information The Company may require each seller of Registrable Securities as to which any registration is being effected to furnish, and such seller shall furnish, to the Company such information regarding the distribution of such securities as the Company may from time to time reasonably request in writing.

  • Event Information Number: 230202 Addendum 1 Title: Security Systems Products and Services Type: Request for Proposal Issue Date: 2/2/2023 Deadline: 3/17/2023 03:00 PM (CT) Notes: This is a solicitation issued by The Interlocal Purchasing System (TIPS), a department of Texas Region 8 Education Service Center. It is an Indefinite Delivery, Indefinite Quantity ("IDIQ") solicitation. It will result in contracts that provide, through adoption/"piggyback" an indefinite quantity of supplies/services, during a fixed period of time, to TIPS public entity and qualifying non-profit "TIPS Members" throughout the nation. Thus, there is no specific project or scope of work to review. Rather this solicitation is issued as a prospective award for utilization when any TIPS Member needs the goods or services offered during the life of the agreement. IF YOU CURRENTLY HOLDS TIPS CONTRACT 200203 SECURITY SYSTEMS PRODUCTS AND SERVICES ("200203"). YOU MUST RESPOND TO THIS SOLICITATION TO PREVENT LAPSE OF CONTRACT UNLESS YOU HOLD ANOTHER CURRENT TIPS CONTRACT THAT COVERS ALL OF YOUR SECURITY OFFERINGS. THIS AWARDED CONTRACT WILL REPLACE YOUR EXPIRING TIPS CONTRACT 200203. Address: Region 8 Education Service Center 0000 XX Xxxxxxx 000 Xxxxx Pittsburg, TX 75686 Phone: +0 (000) 000-0000 Email: xxxx@xxxx-xxx.xxx Contact: Xxxxxx Xxxxxxx Address: 000 - 00000 Xxxxx Xxx. Abbotsford, BC V2T6H1 Canada Phone: (000) 000-0000 Fax: (000) 000-0000 Toll Free: (000) 000-0000 Email: xxxxxxxxx@xxxxxxxxxx-xxxxxxx.xxx Web Address: xxx.xxxxxxxxxx-xxxxxxx.xxx By submitting your response, you certify that you are authorized to represent and bind your company. Pricing Form 1 must be downloaded from the “Attachments” section of the IonWave eBid System, reviewed, properly completed as instructed, and uploaded to this location. Pricing Form 2 must be downloaded from the “Attachments” section of the IonWave eBid System, reviewed, properly completed as instructed, and uploaded to this location.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!